Osteoporosis, a systemic skeletal disease, is characterized by low bone mass and architectural deterioration, leading to increased bone fragility. With an aging population, the burden of osteoporosis is rising, making its effective management imperative. This article aims to outline recent advancements and existing challenges in osteoporosis management.
Recent years have seen significant advancements in osteoporosis diagnostics and therapeutics. High-resolution peripheral quantitative computed tomography (HR-pQCT) and trabecular bone score (TBS) have improved the assessment of bone quality. Therapeutically, new drugs such as Romosozumab, a monoclonal antibody, have shown promising results in increasing bone formation and decreasing bone resorption.
Despite advancements, challenges persist. Identifying individuals at risk remains difficult due to the asymptomatic nature of osteoporosis until a fracture occurs. Adherence to medication is another challenge due to side effects and the perception that osteoporosis is a natural part of aging. Furthermore, the long-term safety of new drugs is yet to be established.
Healthcare professionals play a pivotal role in managing osteoporosis. They need to educate patients about the importance of regular bone health checks, proper nutrition, and exercise. They also need to address patients' concerns about medication side effects and emphasize the necessity of adherence to treatment plans.
While advancements in osteoporosis management have improved patient outcomes, challenges persist. Healthcare professionals need to take a proactive approach in educating patients, promoting early detection, and ensuring adherence to treatment plans. As research progresses, it is hoped that the management of osteoporosis will continue to improve, reducing the burden of this debilitating disease.
1.
Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions
2.
Sevabertinib Approved for First-Line Mutated NSCLC
3.
After three years, responses to mounetuzumab in follicular lymphoma are still stable.
4.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
5.
AI can identify women at risk of breast cancer years in advance: Study
1.
Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy
2.
Pediatric Tumor Microenvironment Evolution: Mechanisms, Clinical Impact, and Therapeutic Implications
3.
Hematopoietic Stem Cell Activity Biomarkers in Aging
4.
Bone-Marrow Immune Cell Competition: Mechanisms, Clinical Implications, and Emerging Therapeutic Perspectives
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Emerging Concepts in Hematology
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation